Communications Biology · 2022 · 34 citations · 66 references
Life SciencesImmunologyMicrobiologyBacteriologyCarcinogenesisMicrobial PathogenesisBacterial InfectionsBacterial PathogenesisCervical CancerCervical Intraepithelial NeoplasiaGynecologic InfectionsMicrobial Omics IntegrationBacterial Vaginosis - Associated Cervical InfectionFusobacterium SpeciesHost-microbiome Interactions In CancerHuman MicrobiomeInfection-associated Tumor DevelopmentMicrobial Etiology Of CancerMicrobiome-associated CarcinogenesisProinflammatory Mediators
Specific bacteria of the human microbiome influence carcinogenesis at diverse anatomical sites. Bacterial vaginosis (BV) is the most common vaginal disorder in premenopausal women that is associated with gynecologic sequelae, including cervical cancer. BV-associated microorganisms, such as Fusobacterium, Lancefieldella, Peptoniphilus, and Porphyromonas have been associated with gynecologic and other cancers, though the pro-oncogenic mechanisms employed by these bacteria are poorly understood. Here, we integrated a multi-omics approach with our three-dimensional (3-D) cervical epithelial cell culture model to investigate how understudied BV-associated bacteria linked to gynecologic neoplasia influence hallmarks of cancer in vitro. Lancefieldella parvulum and Peptoniphilus lacrimalis elicited robust proinflammatory responses in 3-D cervical cells. Fusobacterium nucleatum and Fusobacterium gonidiaformans modulated metabolic hallmarks of cancer corresponding to accumulation of 2-hydroxyglutarate, pro-inflammatory lipids, and signs of oxidative stress and genotoxic hydrogen sulfide. This study provides mechanistic insights into how gynecologic cancer-associated bacteria might facilitate a tumor-promoting microenvironment in the human cervix.
66
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text
Chronic Inflammation in Cancer Development
Gabriele Multhoff, M. Molls, Jürgen Radons · Frontiers in Immunology · 2012 · 571 citations · Full text
Life Sciences, Immunology, Oncology +17